Litcius/Paper detail

Current perspective of new anti-Wolbachial and direct-acting macrofilaricidal drugs as treatment strategies for human filariasis

Alexandra Ehrens, Achim Hoerauf, Marc P. Hübner

2022PubMed27 citationsDOIOpen Access PDF

Abstract

), the Bill & Melinda Gates Foundation, and partners from academia and industry, several new promising macrofilaricidal drug candidates were identified, which will be discussed in this review.

Topics & Concepts

Lymphatic filariasisOnchocerciasisIvermectinFilariasisDiethylcarbamazineNeglected tropical diseasesMedicineAdverse effectPublic healthMass drug administrationAlbendazoleTransmission (telecommunications)Environmental healthImmunologyPharmacologySurgeryVeterinary medicineHelminthsPathologyPopulationElectrical engineeringEngineeringParasitic Diseases Research and TreatmentInsects and Parasite InteractionsParasites and Host Interactions
Current perspective of new anti-Wolbachial and direct-acting macrofilaricidal drugs as treatment strategies for human filariasis | Litcius